Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
are recruiting an enthusiastic and collaborative post-doctoral research associate with expertise in formal methods, machine learning, control theory, numerical analysis, or a related discipline, with a strong
-
the research component of your ACL. However you will be required to obtain an ACL in one of the clinical specialties listed above or on the link. Applicants must hold a PhD/MD at time of appointment, have
-
machine learning, agent-based modelling and multi-criteria decision analysis. Excellent scientific writing, team work, organisational skills and communication skills with a range of stakeholders are
-
delivery of activity. Producing business readiness gap analysis and business readiness planning. Supporting the analysis, management, and ensuing requirements documentation is up to date. Supporting
-
this project we will develop a novel experimental system that is complex yet tractable, enabling rich, coordinated multi-omics analysis coupled with computational modelling to deliver deep mechanistic insight
-
, which you will lead, under the supervision of Prof David Wedge. Collectively, the team has expertise in the analysis of multilevel omic and imaging data; data integration and machine learning; and risk
-
. The successful candidate is expected to have experience in artificial intelligence and machine learning, big data processing, cardiac image analysis, data visualisation and statistical methods. Strong
-
established behavioural tests. Post-mortem analysis will include immunohistochemistry and RNA sequencing to identify candidate treatments targeting menopause-sensitive vasodilation pathways. Full training will
-
-depth qualitative analysis, including case studies, questionnaires, interviews, and workshops with policymakers and relevant stakeholders. We are specifically looking for someone with research experience
-
spectroscopy) Conducting behavioural testing for cognitive function Post-mortem analysis (e.g. immunohistochemistry, RNA sequencing) to identify candidate treatments targeting menopause-sensitive vasodilation